CIK 0001506251 · Non-accelerated filer<br>Smaller reporting company
Citius Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CTXR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273425913
- Phone
- (908) 967-6676
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- Trail One, Inc., TrailOne, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-25 | Mazur Leonard L Chief Executive Officer | Returned to the company · Warrant to Purchase Common Stock | −2,234,700 | 0 | ||
| 2024-09-25 | Mazur Leonard L Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +2,234,700 | 2,234,700 | ||
| 2024-08-14 | HOLUBIAK MYRON Z Vice Chairman | Returned to the company · Warrant to Purchase Common Stock | −784,314 | 0 | ||
| 2024-08-14 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Warrant to Purchase Common Stock | +784,314 | 784,314 | ||
| 2024-08-14 | Mazur Leonard L Chief Executive Officer | Returned to the company · Warrant to Purchase Common Stock | −3,137,255 | 0 | ||
| 2024-08-14 | Mazur Leonard L Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +3,137,255 | 3,137,255 | ||
| 2024-04-03 | HOLUBIAK MYRON Z Vice Chairman | Returned to the company · Warrant to Purchase Common Stock | −129,450 | 0 | ||
| 2024-04-03 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Warrant to Purchase Common Stock | +129,450 | 129,450 | ||
| 2024-04-03 | Mazur Leonard L Chief Executive Officer | Returned to the company · Warrant to Purchase Common Stock | −1,165,048 | 0 | ||
| 2024-04-03 | Mazur Leonard L Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +1,165,048 | 1,165,048 | ||
| 2024-03-14 | Smith Robert Joseph Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +75,000 | 75,000 | ||
| 2024-03-13 | Holuka Eugene Myron Director | Option exercise | +2,415 | $0.02 | $36 | 2,415 |
| 2024-03-13 | Holuka Eugene Myron Director | Shares withheld for taxes | −48 | $0.75 | $36 | 2,367 |
| 2024-03-13 | Holuka Eugene Myron Director | Option exercise · Stock Option (Right to Purchase Common Stock) | −2,415 | 0 | ||
| 2024-03-04 | Webb Carol Director | Option exercise | +12,071 | $0.02 | $181 | 12,071 |
| 2024-03-04 | Webb Carol Director | Shares withheld for taxes | −236 | $0.77 | $181 | 11,835 |
| 2024-03-04 | Webb Carol Director | Option exercise · Stock Option (Right to Purchase Common Stock) | −12,071 | 0 | ||
| 2023-10-10 | Webb Carol Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2023-10-10 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2023-10-10 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Options to Purchase Common Stock | +400,000 | 400,000 |
Page 2 of 8 · 156 trades